REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 102 filers reported holding REGULUS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2018 | $10,000 | -37.5% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $16,000 | 0.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | -15.8% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $19,000 | +26.7% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | -6.2% | 15,000 | +50.0% | 0.00% | 0.0% |
| Q1 2017 | $16,000 | -27.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $22,000 | -33.3% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $33,000 | +13.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $29,000 | -68.8% | 10,000 | -6.6% | 0.00% | -66.7% |
| Q4 2015 | $93,000 | – | 10,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 13,685,204 | $9,021,000 | 0.88% |
| NEA Management Company, LLC | 10,989,910 | $7,244,000 | 0.34% |
| Boxer Capital, LLC | 1,697,802 | $1,121,000 | 0.13% |
| ASCEND CAPITAL, LLC | 1,068,361 | $705,000 | 0.03% |
| Rhenman & Partners Asset Management AB | 492,878 | $325,000 | 0.03% |
| South Dakota Investment Council | 1,683,601 | $1,110,000 | 0.02% |
| WEDBUSH SECURITIES INC | 82,455 | $54,000 | 0.01% |
| DRW Securities, LLC | 135,000 | $89,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 13,304 | $9,000 | 0.01% |
| Candriam S.C.A. | 500,000 | $330,000 | 0.01% |